Charles Catton

Radiation Oncologist


Princess Margaret Cancer Centre
610 University Avenue, Toronto, Ontario Canada M5G 2M9
Research Interests
High-precision radiotherapy and novel imaging techniques for soft-tissue sarcomas and prostate cancer.
Clinical Interests
GU tumours, prostate cancer, Sarcoma, Development of high-precision radiation techniques for the treatment of GU and soft tissue malignancies
Please contact Faculty Member for more information


  • MD, University of Ottawa
  • FRCPC, Radiation Oncology

Research Synopsis

  • A Phase III trial of Hypofractionated vs conventional escalated dose radiotherapy for localized prostate cancer (P.I.) (Acronym PROFIT, sponsored by Ontario Clinical Oncology Group)
  • A Phase III trial of immediate vs early salvage post-operative radiotherapy for limited-stage prostate cancer, with long term, short term or no androgen ablation. (P.I.) (Acronym RADICALS, NCIC-CTG designation PR-13. Sponsors NCIC-CTG and MRC UK)



Professor, Department of Radiation Oncology, University of Toronto
Radiation Oncologist, Department of Radiation Oncology, Princess Margaret Hospital/ University Health Network
GU site group leader, Sarcoma site group leader, Radiation Medicine Program Princess Margaret Hospital/ University Health Network
Chair, Sarcoma Services Oversight Committee, CancerCare Ontario